CHRISTOPHE SIMON/AFP via Getty Images

STAT+ | Europe, with ambitions to poach American scientists, faces pressures of its own

French universities are offering refuge to U.S. researchers as NIH funding faces steep cuts under Trump. Europe positions itself as a science haven.

By Andrew Joseph

STAT+ | 11.8 million to lose health insurance under Senate Republican tax bill, CBO projects

CBO estimates suggest the Senate GOP's tax bill would leave nearly 1 million more people without insurance than the House version.

By Daniel Payne

STAT+ | HHS to continue funding cancer prevention, tracking work in states after uncertainty

The funding had been in doubt, producing anxieties among local officials. Efforts could still be affected by HHS' reorganization.

By Isabella Cueto

Adobe

Opinion: RFK Jr. says medical journals are ‘corrupt.’ As former NEJM editors, we know he’s wrong

Absent a change in how research is funded, medical journals can only manage conflicts of interest; they can’t prevent them.

By Marcia Angell, Jerome P. Kassirer, and Robert Steinbrook

STAT+ | Many medical devices deemed ‘breakthrough’ by FDA are backed by patchy evidence

As FDA chief Marty Makary considers immediate insurance coverage for breakthrough devices, new study finds mixed results from the breakthrough program.

By Katie Palmer

STAT+ | At Aspen Ideas, a life science VC sees cause for long-term optimism despite a rocky market

Owens, who turned to VC work after a big success with Grail, says despite market uncertainty, "there's many reasons to be excited about what's possible."

By Jonathan Wosen

Francisco Seco/AP

STAT+ | New study challenges understanding of how age, chronic diseases and inflammation are linked

People in non-industrialized societies show little inflammaging with age — raising big questions about aging, lifestyle, and chronic disease risk.

By Marissa Russo

STAT+ | New blood test could predict preeclampsia in the first trimester

Researchers say a new blood test could help doctors identify patients at high risk for preeclampsia earlier, and avoid severe pregnancy complications.

By Veronica Paulus

Opinion: The U.S. must invest in mRNA vaccines against pandemic influenza viruses now

The Trump administration recently canceled contracts to develop and produce mRNA vaccines against pandemic influenza. That could be a disaster.

By Steve Osofsky